Heron Therapeutics | HRTX - Market Capitalization

Stock Price
0.80
Daily Change
0.04 4.58%
Monthly
-33.33%
Yearly
-65.07%
Q1 Forecast
0.76

Heron Therapeutics reported $115M in Market Capitalization this March of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
ALKERMES USD 4.47B 146M Mar/2026
Alnylam Pharmaceuticals USD 52.54B 7.24B Dec/2025
Amarin USD 308M 18M Mar/2026
ANI Pharmaceuticals USD 1.77B 269M Dec/2025
Anika Therapeutics USD 210M 71M Mar/2026
Arrowhead Research USD 9.02B 4.25B Dec/2025
Eisai JPY 1.4T 85.07B Mar/2026
Emergent BioSolutions USD 125M 51M Dec/2023
Esperion Therapeutics USD 475M 410M Mar/2026
GlaxoSmithKline GBP 74.36B 10.31B Dec/2025
Heron Therapeutics USD 133M 105M Mar/2026
Insmed USD 37.12B 6.68B Dec/2025
Merck USD 261.26B 51.62B Dec/2025
Neurocrine Biosciences USD 14.14B 218M Dec/2025
Pacira USD 1.06B 94M Dec/2025
Regeneron Pharmaceuticals USD 81.12B 21.53B Dec/2025
Roche Holding CHF 266.34B 55.46B Dec/2025
Ultragenyx Pharmaceutical USD 2.22B 680M Dec/2025
Veracyte USD 3.33B 627M Dec/2025
Vertex Pharmaceuticals USD 115.03B 14.61B Dec/2025